The diagnostic value of the IDEAL-T2WI sequence in dysthyroid optic neuropathy: a quantitative analysis of the optic nerve and cerebrospinal fluid in the optic nerve sheath
- PMID: 33993334
- DOI: 10.1007/s00330-021-08030-5
The diagnostic value of the IDEAL-T2WI sequence in dysthyroid optic neuropathy: a quantitative analysis of the optic nerve and cerebrospinal fluid in the optic nerve sheath
Abstract
Objectives: To evaluate the optic nerve and CSF in the optic nerve sheath as imaging markers of dysthyroid optic neuropathy (DON).
Methods: In this single-centre retrospective study, orbital images of 30 consecutive participants (54 orbits) with DON, 30 patients (60 orbits) with thyroid-associated ophthalmopathy (TAO) without DON, and 19 healthy controls (HCs; 38 orbits) were analysed. The diameter and cross-sectional area of the optic nerve and its sheath, water fraction of the optic nerve, and volume of the fluid in the optic nerve sheath were measured and compared. The associations between MR parameters and clinical measures were assessed using correlation analysis.
Results: The diameter and water fraction of the optic nerve (3 mm and 6 mm behind the eyeball), optic nerve subarachnoid space (ONSS) (3 mm and 6 mm behind the eyeball), and subarachnoid fluid volume in the optic nerve sheath were significantly greater in the DON group than in the TAO group (p < 0.01) or HC group (p < 0.01). ROC analysis showed that ONSS 3 mm behind the eyeball (ONSS3) was a robust predictor of DON (AUC = 0.957, sensitivity = 0.907, specificity = 0.9). Water fraction of the optic nerve 3 mm behind the eyeball (water fraction3) had the best specificity (0.967). Water fraction3, fluid volume in the optic nerve sheath, and optic nerve diameter (3 mm behind the eyeball) were correlated with clinical measures (i.e. clinical activity score, mean defect, and pattern standard deviation).
Conclusions: Increased water fraction of the optic nerve and ONSS3 are promising and easily accessible radiological markers for diagnosing DON.
Key points: • The water fraction of the optic nerve and optic nerve subarachnoid space (ONSS) are greater in patients with dysthyroid optic neuropathy (DON) than in patients with thyroid-associated ophthalmopathy (TAO) without DON. • The optic nerve and the cerebrospinal fluid in the optic nerve sheath measures are associated with visual dysfunction. • The water fraction of the optic nerve and ONSS may be promising imaging markers for diagnosing DON.
Keywords: Cerebrospinal fluid in the optic nerve sheath; Dysthyroid optic neuropathy; Magnetic resonance imaging; Optic nerve; Quantitative water-fat sequence.
© 2021. European Society of Radiology.
Similar articles
-
A Prediction Model for Detecting Dysthyroid Optic Neuropathy Based on Clinical Factors and Imaging Markers of the Optic Nerve and Cerebrospinal Fluid in the Optic Nerve Sheath.Curr Med Sci. 2024 Aug;44(4):827-832. doi: 10.1007/s11596-024-2890-2. Epub 2024 Aug 3. Curr Med Sci. 2024. PMID: 39096474
-
Diagnosis of dysthyroid optic neuropathy: combined value of orbital MRI and intracranial visual pathway diffusion kurtosis imaging.Eur Radiol. 2024 Aug;34(8):5401-5411. doi: 10.1007/s00330-024-10615-9. Epub 2024 Jan 26. Eur Radiol. 2024. PMID: 38276980
-
Extraocular muscle volume index at the orbital apex with optic neuritis: a combined parameter for diagnosis of dysthyroid optic neuropathy.Eur Radiol. 2023 Dec;33(12):9203-9212. doi: 10.1007/s00330-023-09848-x. Epub 2023 Jul 5. Eur Radiol. 2023. PMID: 37405499
-
Imaging of dysthyroid optic neuropathy.Eur J Ophthalmol. 2024 Sep;34(5):1346-1354. doi: 10.1177/11206721231199367. Epub 2023 Sep 6. Eur J Ophthalmol. 2024. PMID: 37671438 Review.
-
The effect of orbital radiation therapy on thyroid-associated orbitopathy complicated with dysthyroid optic neuropathy.Front Med. 2017 Sep;11(3):359-364. doi: 10.1007/s11684-017-0528-5. Epub 2017 May 13. Front Med. 2017. PMID: 28500433 Review.
Cited by
-
Immune-related visual dysfunction in thyroid eye disease: a combined orbital and brain neuroimaging study.Eur Radiol. 2024 Jul;34(7):4516-4526. doi: 10.1007/s00330-023-10309-8. Epub 2023 Dec 19. Eur Radiol. 2024. PMID: 38112763
-
Fat-suppression T2 relaxation time and water fraction predict response to intravenous glucocorticoid therapy for thyroid-associated ophthalmopathy.Eur Radiol. 2025 Feb;35(2):957-967. doi: 10.1007/s00330-024-10868-4. Epub 2024 Aug 2. Eur Radiol. 2025. PMID: 39093414
-
The Value of MRI and Radiomics for the Diagnostic Evaluation of Thyroid-Associated Ophthalmopathy.Diagnostics (Basel). 2025 Feb 6;15(3):388. doi: 10.3390/diagnostics15030388. Diagnostics (Basel). 2025. PMID: 39941318 Free PMC article. Review.
-
Current insights of applying MRI in Graves' ophthalmopathy.Front Endocrinol (Lausanne). 2022 Sep 29;13:991588. doi: 10.3389/fendo.2022.991588. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36267571 Free PMC article.
-
A Prediction Model for Detecting Dysthyroid Optic Neuropathy Based on Clinical Factors and Imaging Markers of the Optic Nerve and Cerebrospinal Fluid in the Optic Nerve Sheath.Curr Med Sci. 2024 Aug;44(4):827-832. doi: 10.1007/s11596-024-2890-2. Epub 2024 Aug 3. Curr Med Sci. 2024. PMID: 39096474
References
-
- Khong JJ, Finch S, De Silva C et al (2016) Risk factors for Graves’ orbitopathy; the Australian Thyroid-Associated Orbitopathy Research (ATOR) Study. J Clin Endocrinol Metab 101:2711–2720 - PubMed
-
- Saeed P, Tavakoli Rad S, Bisschop P (2018) Dysthyroid optic neuropathy. Ophthal Plast Reconstr Surg 34:S60–S67 - PubMed
-
- Kazim M, Trokel S, Moore S (1991) Treatment of acute Graves orbitopathy. Ophthalmology 98:1443–1448 - PubMed
-
- Campi I, Vannucchi G, Salvi M (2016) Therapy of endocrine disease: endocrine dilemma: management of Graves’ orbitopathy. Eur J Endocrinol 175:R117–R133 - PubMed
-
- McKeag D, Lane C, Lazarus JH et al (2007) Clinical features of dysthyroid optic neuropathy: a European Group on Graves’ Orbitopathy (EUGOGO) survey. Br J Ophthalmol 91:455–458 - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical